A carregar...

Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement

Approximately 22,700 Canadian women were expected to be diagnosed with breast cancer in 2012. Despite improvements in screening and adjuvant treatment options, a substantial number of postmenopausal women with hormone receptor positive (hr+) breast cancer will continue to develop metastatic disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pritchard, K.I., Gelmon, K.A., Rayson, D., Provencher, L., Webster, M., McLeod, D., Verma, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3557331/
https://ncbi.nlm.nih.gov/pubmed/23443928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.20.1316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!